DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,565 filers reported holding DANAHER CORPORATION in Q2 2020. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $67,057 | -10.6% | 279,288 | -6.1% | 1.08% | -17.1% |
| Q1 2023 | $74,985 | -50.4% | 297,560 | -47.7% | 1.31% | -4.1% |
| Q4 2022 | $151,158 | -99.8% | 569,332 | +105.3% | 1.36% | -5.8% |
| Q3 2022 | $71,673,000 | +42.4% | 277,319 | +39.7% | 1.45% | +52.8% |
| Q2 2022 | $50,325,000 | +1526.0% | 198,458 | +1780.8% | 0.95% | +1960.9% |
| Q1 2022 | $3,095,000 | -28.4% | 10,552 | -19.7% | 0.05% | -17.9% |
| Q4 2021 | $4,325,000 | +10.6% | 13,144 | +2.3% | 0.06% | 0.0% |
| Q3 2021 | $3,911,000 | -9.1% | 12,853 | -19.9% | 0.06% | -8.2% |
| Q2 2021 | $4,303,000 | -41.2% | 16,037 | -51.0% | 0.06% | +13.0% |
| Q1 2021 | $7,321,000 | +97.3% | 32,746 | +96.0% | 0.05% | 0.0% |
| Q4 2020 | $3,711,000 | +3.2% | 16,709 | 0.0% | 0.05% | -26.0% |
| Q3 2020 | $3,596,000 | +14.6% | 16,709 | -5.9% | 0.07% | +4.3% |
| Q2 2020 | $3,137,000 | +12.9% | 17,757 | -11.5% | 0.07% | -12.5% |
| Q1 2020 | $2,778,000 | -9.8% | 20,074 | 0.0% | 0.08% | +8.1% |
| Q4 2019 | $3,081,000 | +6.3% | 20,074 | 0.0% | 0.07% | -2.6% |
| Q3 2019 | $2,898,000 | +1.0% | 20,074 | 0.0% | 0.08% | -1.3% |
| Q2 2019 | $2,868,000 | – | 20,074 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
| Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
| Third Point | 2,490,000 | $730,392,000 | 9.51% |
| Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
| 11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
| Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
| Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
| Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
| Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |